Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Epidemiology
Reference30 articles.
1. Osteosarcoma: improvement in survival limited to high-grade patients only;Jawad;J Cancer Res Clin Oncol,2011
2. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program;Mirabello;Cancer,2009
3. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols;Bielack;J Clin Oncol,2002
4. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience;Meyers;J Clin Oncol,1992
5. Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide;Bacci;Ann Oncol,2003
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism;BMC Cancer;2024-02-02
2. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction;Frontiers in Immunology;2023-12-15
3. Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I–II Hepatocellular Carcinoma;Annals of Surgical Oncology;2023-09-07
4. Socioeconomic disparities in musculoskeletal oncology;Journal of Surgical Oncology;2023-08-04
5. Formulation and validation of a baseline prognostic score for osteosarcoma treated uniformly with a non-high dose methotrexate-based protocol from a low middle income healthcare setting: a single centre analysis of 594 patients;Frontiers in Oncology;2023-04-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3